Parsippany, New Jersey, March 10, 2010 - Alvogen, the US-based pharmaceutical company, today announced that Peter Keil has joined the Alvogen senior management team. He is the new regional manager for Alvogen in Asia and will lead the commercial activities for all countries in the region except China and India. Keil comes with over 15 years’ experience in Asia’s generic industry after working in quality assurance, global procurement, commercial divisions and most recently as country head in Thailand for Sandoz. Keil graduated from the University of Innsbruck, Austria, in Business Administration and is a chemical engineer from the Chemotechnikum in Graz, Austria.
“Peter Keil has a solid leadership background in the generic industry and brings valuable experience to our expansion plans into new markets in Asia,” said Robert Wessman, Executive Chairman of Alvogen.
Offices around the world – Alvogen continues to grow its marketing network and has identified over 20 emerging markets in Europe, Asia and Latin America as its priorities for entry. Through a highly refined selection process, Alvogen targets complex generic products that have the potential for reduced market competition. The company has built an industry-leading internal development capability and a strong and effective network of industry partners that continue to support Alvogen’s ambitious growth plans.